LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC
Clinical trials for LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC explained in plain language.
Never miss a new study
Get alerted when new LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC trials appear
Sign up with your email to follow new studies for LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to calm deadly immune storm in rare blood disease
Disease control Recruiting nowThis study tests a drug called golidocitinib for people with hemophagocytic lymphohistiocytosis (HLH), a rare condition where the immune system attacks the body. About 28 adults aged 14 to 70 with new or returning HLH will take the drug alone. The goal is to see if it can improve…
Matched conditions: LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC
Phase: PHASE2, PHASE3 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated May 26, 2026 05:17 UTC
-
Scientists launch deep dive into mysterious immune disease sHLH
Knowledge-focused Recruiting nowThis study aims to understand why some adults develop secondary hemophagocytic lymphohistiocytosis (sHLH), a serious immune condition that causes fevers and can be life-threatening. Researchers will follow 300 adults with sHLH for up to a year, collecting blood samples and medica…
Matched conditions: LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC